We are live on
!
Find out more
ZCM
Zebra Capital Management Portfolio holdings
AUM
$20M
1-Year Est. Return
2.24%
This Fund
S&P 500
This Quarter
Est. Return
-1.46%
1 Year Est. Return
+2.24%
3 Year Est. Return
+142.1%
5 Year Est. Return
+107.07%
10 Year Est. Return
+252.16%
AUM
$82.5M
AUM Growth
-$2.76M
(-3.2%)
Cap. Flow
-$169K
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
17.9%
Holding
227
New
67
Increased
20
Reduced
84
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LHCG
LHC Group LLC
LHCG
|
+$1.8M |
| 2 |
Opko Health
OPK
|
+$1.75M |
| 3 |
UFP Industries
UFPI
|
+$1.64M |
| 4 |
Cushman & Wakefield Ltd
CWK
|
+$1.6M |
| 5 |
Amkor Technology
AMKR
|
+$1.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Insight Enterprises
NSIT
|
+$2.03M |
| 2 |
LCI Industries
LCII
|
+$1.32M |
| 3 |
MYR Group
MYRG
|
+$1.29M |
| 4 |
Upbound Group
UPBD
|
+$1.22M |
| 5 |
Helen of Troy
HELE
|
+$1.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Financials | 14.43% |
| 3 | Industrials | 13.44% |
| 4 | Technology | 13.01% |
| 5 | Consumer Discretionary | 12.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Corcept Therapeutics
CORT
$12.2B
| $307K | 0.37% |
+15,586
| New | +$326K |
|
102
Rocky Brands
RCKY
$357M
| $305K | 0.37% |
+6,399
| New | +$318K |
|
|
EBTC
103
DELISTED
Enterprise Bancorp
EBTC
| $301K | 0.36% |
8,371
-1,540
| -16% | -$51.6K |
|
104
Vericel Corp
VCEL
$2.36B
| $299K | 0.36% |
6,124
-1,355
| -18% | -$70.1K |
|
105
Lifetime Brands
LCUT
$192M
| $298K | 0.36% |
+16,400
| New | +$274K |
|
106
Franklin Electric
FELE
$4.6B
| $297K | 0.36% |
3,721
-2,883
| -44% | -$237K |
|
107
Univest Financial
UVSP
$1.23B
| $294K | 0.36% |
+10,738
| New | +$288K |
|
|
ITIC
108
Investors Title Co
ITIC
$548M
| $292K | 0.35% |
+1,600
| New | +$288K |
|
109
RPC Inc
RES
$1.22B
| $285K | 0.35% |
58,540
+38,782
| +196% | +$162K |
|
|
PSB
110
DELISTED
PS Business Parks, Inc.
PSB
| $279K | 0.34% |
+1,778
| New | +$275K |
|
111
Horizon Bancorp
HBNC
$1.05B
| $276K | 0.33% |
+15,166
| New | +$262K |
|
112
DXP Enterprises
DXPE
$2.45B
| $275K | 0.33% |
9,299
-5,798
| -38% | -$178K |
|
113
LeMaitre Vascular
LMAT
$2.31B
| $274K | 0.33% |
+5,151
| New | +$290K |
|
|
KW
114
DELISTED
Kennedy-Wilson Holdings
KW
| $271K | 0.33% |
12,958
-7,213
| -36% | -$150K |
|
115
MiMedx Group
MDXG
$596M
| $265K | 0.32% |
+43,756
| New | +$493K |
|
|
ATRS
116
DELISTED
Antares Pharma, Inc.
ATRS
| $264K | 0.32% |
72,365
+43,927
| +154% | +$178K |
|
117
REX American Resources
REX
$1.41B
| $261K | 0.32% |
+19,644
| New | +$265K |
|
118
Rimini Street
RMNI
$441M
| $261K | 0.32% |
+26,999
| New | +$234K |
|
119
HBT Financial
HBT
$1.3B
| $249K | 0.3% |
16,044
-664
| -4% | -$10.7K |
|
120
Community Trust Bancorp
CTBI
$1.43B
| $248K | 0.3% |
+5,883
| New | +$238K |
|
121
Global Industrial
GIC
$1.36B
| $248K | 0.3% |
+6,550
| New | +$246K |
|
122
South Plains Financial
SPFI
$840M
| $247K | 0.3% |
10,120
-3,370
| -25% | -$78.3K |
|
123
Perdoceo Education
PRDO
$1.98B
| $246K | 0.3% |
23,253
-4,905
| -17% | -$55.2K |
|
124
Hawkins
HWKN
$2.56B
| $244K | 0.3% |
6,999
-3,772
| -35% | -$130K |
|
125
Puma Biotechnology
PBYI
$399M
| $240K | 0.29% |
34,295
+3,390
| +11% | +$25.4K |
|
Similar funds
CM
NPAM
6C
SCU
FFG
KE
GFT
CCM
Zebra Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Zebra Capital Management held 227 positions worth $82.5M, down 3.2% from $85.3M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Zebra Capital Management's Q3 2021 filing shows 67 new, 20 increased, 84 reduced and 45 closed positions. Its largest new stake was LHC Group LLC: 9,610 shares worth $1.51M. The largest sale was Insight Enterprises, an estimated $2.03M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Zebra Capital Management's largest Q3 2021 buy was LHC Group LLC: 9,610 shares worth $1.51M.
- Zebra Capital Management added most to Emergent Biosolutions in Q3 2021, an estimated $517K increase.
- Zebra Capital Management's biggest Q3 2021 reduction was IDT Corp, cutting an estimated $953K.
- Zebra Capital Management fully exited Insight Enterprises in Q3 2021, selling an estimated $2.03M.
- Zebra Capital Management's ten largest holdings make up 18% of its $82.5M portfolio in Q3 2021.
- Zebra Capital Management opened 67 new positions and closed 45 in Q3 2021.
- Zebra Capital Management's portfolio value fell 3.2% quarter-over-quarter to $82.5M.
Based on Zebra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.